CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 trial evaluating empagliflozin added to linagliptin in Japanese adults with type 2 diabetes has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2019-02-15